Peptides Derived from a Plant Protease Inhibitor of the Coagulation Contact System Decrease Arterial Thrombus...

Area of Science:

• Biochemistry
• Pharmacology
• Biotechnology

Background:

• Plant protein inhibitors, like Delonix regia trypsin inhibitor (DrTI), exhibit anticoagulant properties.
• DrTI targets serine proteases and key coagulation factors (plasma kallikrein, factor XIIa, factor XIa).

Purpose of the Study:

• To evaluate the antithrombotic potential of two synthetic peptides derived from DrTI.
• To elucidate the mechanisms underlying thrombus formation and explore new antithrombotic strategies.

Main Methods:

• In vitro assessment of hemostasis parameters, including activated Partial Thromboplastin Time (aPTT) and platelet aggregation (ADP, arachidonic acid).
• In vivo murine models for arterial thrombosis (photochemical injury) and platelet-endothelial interactions (intravital microscopy).

Main Results:

• Both peptides prolonged aPTT and inhibited platelet aggregation in vitro.
• In vivo, peptides significantly extended artery occlusion time and altered platelet adhesion/aggregation.
• No significant increase in bleeding time was observed in treated murine models.

Conclusions:

• The synthetic DrTI-derived peptides demonstrate significant antithrombotic activity.
• These peptides hold considerable biotechnological potential for developing novel antithrombotic therapies.